Top pharma blogs Secrets
January 21, 2025 In 21 CFR 211.94 it is actually mentioned that “Drug product containers and closures shall not be reactive, additive, or absorptive to alter the safety, id, strength, top quality or purity from the drug further than the official or founded demands.” While the code makes this statement, and if expanded on during the relevant FDA